[Zopiclone and delirium: a case report].
M
M
David
J L
JL
Breton
I
I
Guy
S
S
Vandel
D000551:Ambroxol / Q000627:therapeutic use; D000658:Amoxicillin / Q000627:therapeutic use; D053961:Azabicyclo Compounds; D001982:Bronchial Diseases / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000627:therapeutic use; D019818:Clavulanic Acid / Q000627:therapeutic use; D003693:Delirium / Q000139:chemically induced*; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D009241:Ipratropium / Q000627:therapeutic use; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013141:Spiro Compounds / Q000627:therapeutic use; D013726:Terbutaline / Q000627:therapeutic use
D053961:Azabicyclo Compounds; D001993:Bronchodilator Agents; D006993:Hypnotics and Sedatives; D010879:Piperazines; D013141:Spiro Compounds; C515050:zopiclone; D000551:Ambroxol; D019818:Clavulanic Acid; D002939:Ciprofloxacin; D000658:Amoxicillin; D009241:Ipratropium; D013726:Terbutaline; C084775:fenspiride
Zopiclone et délire: à propos d'une observation.